Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,584 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01548118 | Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females | unknown | Phase 1 | 160 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Mar 8, 2012 | clinicaltrials |
| NCT01175447 | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer | completed | Phase 1 | 12 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01175460 | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer | completed | Phase 1 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Mar 6, 2012 | clinicaltrials |
| NCT01260025 | Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor | completed | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2012 | clinicaltrials |
| NCT01148615 | A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors | completed | Phase 1 | 20 | SanofiINDUSTRY | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01474187 | Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer | unknown | Phase 1 | 60 | Fudan UniversityOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT01449942 | Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) | completed | Phase 1 / Phase 2 | 40 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT01431612 | Effects of Adrenergic Drugs on the Fluid Balance During Surgery | completed | Phase 1 / Phase 2 | 60 | Sodertalje HospitalOTHER | 1 | Sep 9, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00981721 | A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 1 | Jun 20, 2011 | clinicaltrials |
| NCT01361529 | Safety Study of FLP Injection to Treat Tumor Patients | unknown | Phase 1 | 30 | Acea Bio (Hangzhou) Co., Ltd.INDUSTRY | 1 | May 27, 2011 | clinicaltrials |
| NCT00997945 | 10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies | completed | Phase 1 | 15 | AstraZenecaINDUSTRY | 1 | May 19, 2011 | clinicaltrials |
| NCT01322776 | Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma | unknown | Phase 1 / Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Mar 25, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01310478 | Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer | unknown | Phase 1 | 15 | Fudan UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01278810 | Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients | unknown | Phase 1 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 28, 2011 | clinicaltrials |
| NCT01235845 | Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Dec 3, 2010 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT01219192 | Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 28, 2010 | clinicaltrials |
| NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | completed | Phase 1 | 350 | Xi'an Jiaotong UniversityOTHER | 1 | Oct 21, 2010 | clinicaltrials |
| NCT01226030 | Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 21, 2010 | clinicaltrials |
| NCT01218880 | Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | unknown | Phase 1 | 21 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 19, 2010 | clinicaltrials |
| NCT01175096 | Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | unknown | Phase 1 / Phase 2 | 20 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT01063387 | Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer | unknown | Phase 1 | 200 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 5, 2010 | clinicaltrials |
| NCT01043016 | Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors | unknown | Phase 1 | 18 | Fujian Longhua Pharmaceutical Co. LtdOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00639522 | Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | unknown | Phase 1 | 18 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00881101 | Clinical Study of Liposomal Paclitaxel in Chinese Patients | unknown | Phase 1 | 15 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00497250 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | unknown | Phase 1 | 32 | Fudan UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00633490 | Study of Apatinib as an Inhibitor of Tumor Angiogenesis | unknown | Phase 1 | 18 | Fudan UniversityOTHER | 1 | Jul 22, 2008 | clinicaltrials |
| NCT00677456 | Evaluation of Four Reconstructions After Total Gastrectomy | unknown | Phase 1 | 80 | Tang-Du HospitalOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00262327 | Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Jun 20, 2006 | clinicaltrials |
| NCT00054951 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads | unknown | Phase 1 / Phase 2 | 30 | FeRxINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials